279
Views
0
CrossRef citations to date
0
Altmetric
Invited Reviews

Estimating glomerular filtration rate with new equations: can one size ever fit all?

, & ORCID Icon
Pages 549-559 | Received 27 Feb 2023, Accepted 13 May 2023, Published online: 01 Jun 2023

References

  • Miller WG, Bruns DE, Hortin GL, et al. Current issues in measurement and reporting of urinary albumin excretion. Clin Chem. 2009;55(1):24–38.
  • Levin A, Stevens PE. Summary of KDIGO 2012 CKD guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int. 2014;85(1):49–61.
  • Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352(20):2049–2060.
  • Rule AD, Gussak HM, Pond GR, et al. Measured and estimated GFR in healthy potential kidney donors. Am J Kidney Dis. 2004;43(1):112–119.
  • Delanaye P, Jager KJ, Bokenkamp A, et al. CKD: a call for an Age-Adapted definition. J Am Soc Nephrol. 2019;30(10):1785–1805.
  • Shin JI, Sang Y, Chang AR, et al. The FDA metformin label change and racial and sex disparities in metformin prescription among patients with CKD. J Am Soc Nephrol. 2020;31(8):1847–1858.
  • Howard SC, McCormick J, Pui CH, et al. Preventing and managing toxicities of High-Dose methotrexate. Oncologist. 2016;21(12):1471–1482.
  • Levey AS, Titan SM, Powe NR, et al. Kidney disease, race, and GFR estimation. Clin J Am Soc Nephrol. 2020;15(8):1203–1212.
  • Shlipak MG, Tummalapalli SL, Boulware LE, et al. The case for early identification and intervention of chronic kidney disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2021;99(1):34–47.
  • KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. 3, 2013.
  • Seegmiller JC, Eckfeldt JH, Lieske JC. Challenges in measuring glomerular filtration rate: a clinical laboratory perspective. Adv Chronic Kidney Dis. 2018;25(1):84–92.
  • Seegmiller JC, Burns BE, Fauq AH, et al. Iothalamate quantification by tandem mass spectrometry to measure glomerular filtration rate. Clin Chem. 2010;56(4):568–574.
  • Agarwal R, Bills JE, Yigazu PM, et al. Assessment of iothalamate plasma clearance: duration of study affects quality of GFR. Clin J Am Soc Nephrol. 2009;4(1):77–85.
  • Seegmiller JC, Burns BE, Schinstock CA, et al. Discordance between iothalamate and iohexol urinary clearances. Am J Kidney Dis. 2016;67(1):49–55.
  • Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.
  • Puthucheary ZA, Rawal J, McPhail M, et al. Acute skeletal muscle wasting in critical illness. JAMA. 2013;310(15):1591–1600.
  • Cabral BMI, Edding SN, Portocarrero JP, et al. Rhabdomyolysis. Dis Mon. 2020;66(8):101015.
  • Zhang X, Rule AD, McCulloch CE, et al. Tubular secretion of creatinine and kidney function: an observational study. BMC Nephrol. 2020;21(1):108.
  • Stehle T, El Karoui K, Sakka M, et al. Creatinine clearance after cimetidine administration in a new short procedure: comparison with plasma and renal clearances of iohexol. Clin Kidney J. 2020;13(4):587–596.
  • Greenberg N, Roberts WL, Bachmann LM, et al. Specificity characteristics of 7 commercial creatinine measurement procedures by enzymatic and jaffe method principles. Clin Chem. 2012;58(2):391–401.
  • Myers GL, Miller WG, Coresh J, National Kidney Disease Education Program Laboratory Working G, et al. Recommendations for improving serum creatinine measurement: a report from the laboratory working group of the national kidney disease education program. Clin Chem. 2006;52(1):5–18.
  • Meeusen JW, Rule AD, Voskoboev N, et al. Performance of cystatin C- and creatinine-based estimated glomerular filtration rate equations depends on patient characteristics. Clin Chem. 2015;61(10):1265–1272.
  • Satoh-Asahara N, Suganami T, Majima T, et al. Urinary cystatin C as a potential risk marker for cardiovascular disease and chronic kidney disease in patients with obesity and metabolic syndrome. Clin J Am Soc Nephrol. 2011;6(2):265–273.
  • Gharaibeh KA, Hamadah AM, El-Zoghby ZM, et al. Cystatin C predicts renal recovery earlier than creatinine among patients with acute kidney injury. Kidney Int Rep. 2018;3(2):337–342.
  • Frazee E, Rule AD, Lieske JC, et al. Cystatin C-Guided vancomycin dosing in critically ill patients: a quality improvement project. Am J Kidney Dis. 2017;69(5):658–666.
  • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
  • Murata K, Baumann NA, Saenger AK, et al. Relative performance of the MDRD and CKD-EPI equations for estimating glomerular filtration rate among patients with varied clinical presentations. Clin J Am Soc Nephrol. 2011;6(8):1963–1972.
  • Inker LA, Schmid CH, Tighiouart H, Investigators C-E, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20–29.
  • White CA, Allen CM, Akbari A, et al. Comparison of the new and traditional CKD-EPI GFR estimation equations with urinary inulin clearance: a study of equation performance. Clin Chim Acta. 2019;488:189–195.
  • Viberti GC, Keen H, Mackintosh D. Beta 2-microglobulinaemia: a sensitive index of diminishing renal function in diabetics. Br Med J (Clin Res Ed). 1981;282(6258):95–98.
  • White CA, Ghazan-Shahi S, Adams MA. beta-Trace protein: a marker of GFR and other biological pathways. Am J Kidney Dis. 2015;65(1):131–146.
  • Inker LA, Couture SJ, Tighiouart H, Collaborators C-EG, et al. A new Panel-Estimated GFR, including beta(2)-microglobulin and beta-Trace protein and not including race, developed in a diverse population. Am J Kidney Dis. 2021;77(5):673–683 e671.
  • Vyas DA, Eisenstein LG, Jones DS. Hidden in plain Sight - Reconsidering the use of race correction in clinical algorithms. N Engl J Med. 2020;383(9):874–882.
  • Eneanya ND, Yang W, Reese PP. Reconsidering the consequences of using race to estimate kidney function. JAMA. 2019;322(2):113–114.
  • Zelnick LR, Leca N, Young B, et al. Association of the estimated glomerular filtration rate with vs without a coefficient for race with time to eligibility for kidney transplant. JAMA Netw Open. 2021;4(1):e2034004.
  • Hsu CY, Yang W, Parikh RV, Investigators CS, et al. Race, genetic ancestry, and estimating kidney function in CKD. N Engl J Med. 2021;385(19):1750–1760.
  • Duggal V, Thomas IC, Montez-Rath ME, et al. National estimates of CKD prevalence and potential impact of estimating glomerular filtration rate without race. J Am Soc Nephrol. 2021;32(6):1454–1463.
  • Grubbs V. Precision in GFR reporting: let’s stop playing the race card. Clin J Am Soc Nephrol. 2020;15(8):1201–1202.
  • Hsu J, Johansen KL, Hsu CY, et al. Higher serum creatinine concentrations in black patients with chronic kidney disease: beyond nutritional status and body composition. Clin J Am Soc Nephrol. 2008;3(4):992–997.
  • Park J, Jin DC, Molnar MZ, et al. Mortality predictability of body size and muscle mass surrogates in asian vs white and african American hemodialysis patients. Mayo Clin Proc. 2013;88(5):479–486.
  • Levey AS, Tighiouart H, Titan SM, et al. Estimation of glomerular filtration rate with vs without including patient race. JAMA Intern Med. 2020;180(5):793–795.
  • Gama RM, Clery A, Griffiths K, et al. Estimated glomerular filtration rate equations in people of self-reported black ethnicity in the United Kingdom: inappropriate adjustment for ethnicity may lead to reduced access to care. PLoS One. 2021;16(8):e0255869.
  • Umeukeje EM, Koonce TY, Kusnoor SV, et al. Systematic review of international studies evaluating MDRD and CKD-EPI estimated glomerular filtration rate (eGFR) equations in black adults. PLoS One. 2022;17(10):e0276252.
  • Bukabau JB, Yayo E, Gnionsahe A, et al. Performance of creatinine- or cystatin C-based equations to estimate glomerular filtration rate in Sub-Saharan african populations. Kidney Int. 2019;95(5):1181–1189.
  • Moodley N, Hariparshad S, Peer F, et al. Evaluation of the CKD-EPI creatinine based glomerular filtration rate estimating equation in black african and indian adults in KwaZulu-Natal, South Africa. Clin Biochem. 2018;59:43–49.
  • Rocha AD, Garcia S, Santos AB, et al. No Race-Ethnicity adjustment in CKD-EPI equations is required for estimating glomerular filtration rate in the Brazilian population. Int J Nephrol. 2020;2020:2141038.
  • Ashuntantang G, Osafo C, Olowu WA, et al. Outcomes in adults and children with end-stage kidney disease requiring dialysis in Sub-Saharan africa: a systematic review. Lancet Glob Health. 2017;5(4):e408–e417.
  • Stanifer JW, Jing B, Tolan S, et al. The epidemiology of chronic kidney disease in Sub-Saharan africa: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(3):e174-181–e181.
  • Wyatt CM, Schwartz GJ, Owino Ong’or W, et al. Estimating kidney function in HIV-infected adults in Kenya: comparison to a direct measure of glomerular filtration rate by iohexol clearance. PLoS One. 2013;8(8):e69601.
  • Papeta N, Kiryluk K, Patel A, et al. APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy. J Am Soc Nephrol. 2011;22(11):1991–1996.
  • Schwartz EJ, Szczech LA, Ross MJ, et al. Highly active antiretroviral therapy and the epidemic of HIV + end-stage renal disease. J Am Soc Nephrol. 2005;16(8):2412–2420.
  • Wyatt CM, Klotman PE. Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection. Expert Opin Drug Saf. 2006;5(2):275–287.
  • Atta MG, Zook K, Brown TT, et al. Racial adjustment adversely affects glomerular filtration estimates in black americans living with HIV. J Am Soc Nephrol. 2021;32(9):2143–2147.
  • Powe NR. Black kidney function matters: use or misuse of race? JAMA. 2020;324(8):737–738.
  • Delgado C, Baweja M, Crews DC, et al. A unifying approach for GFR estimation: recommendations of the NKF-ASN task force on reassessing the inclusion of race in diagnosing kidney disease. Am J Kidney Dis. 2022;79(2):268–288 e261.
  • Inker LA, Eneanya ND, Coresh J, Chronic Kidney Disease Epidemiology C, et al. New creatinine- and cystatin C-Based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737–1749.
  • Hundemer GL, White CA, Norman PA, et al. Performance of the 2021 Race-Free CKD-EPI creatinine- and cystatin C-Based estimated GFR equations among kidney transplant recipients. Am J Kidney Dis. 2022;80(4):462–472 e461.
  • Fabian J, Kalyesubula R, Mkandawire J, African Research on Kidney Disease C, et al. Measurement of kidney function in Malawi, South Africa, and Uganda: a multicentre cohort study. Lancet Glob Health. 2022;10(8):e1159–e1169.
  • Silva LCF, Rocha BM, Escott GM, et al. Accuracy evaluation of 2021 chronic kidney disease epidemiology collaboration, full age spectrum and european kidney function consortium equations for estimating glomerular filtration rate in type 2 diabetes mellitus and healthy adults. Clin Chim Acta. 2022;534:14–21.
  • Meeusen JW, Rule AD, Voskoboev N, et al. Performance of cystatin C- and Creatinine-Based estimated glomerular filtration rate equations depends on patient characteristics. Clinical Chemistry. 2015;61(10):1265–1272.
  • Gutierrez OM, Sang Y, Grams ME, Chronic Kidney Disease Prognosis C, et al. Association of estimated GFR calculated using Race-Free equations with kidney failure and mortality by black vs Non-Black race. JAMA. 2022;327(23):2306–2316.
  • Butt JH, Adamson C, Docherty KF, et al. Eligibility for pharmacological therapies in heart failure with reduced ejection fraction: implications of the new chronic kidney disease epidemiology collaboration creatinine equation for estimating glomerular filtration rate. Eur J Heart Fail. 2022;24(5):861–866.
  • Orandi BJ, McLeod C, Reed RD, et al. Impact of refitted race-free eGFR formula on obesity pharmacotherapy options. Obesity. 2022;30(11):2204–2212.
  • Husain SA, King KL, Mohan S. Differences between race-based and race-free estimated glomerular filtration rate among living kidney donors. Am J Transplant. 2022;22(5):1504–1505.
  • Sudchada P, Laehn S. Comparisons of GFR estimation using the CKD epidemiology collaboration (CKD-EPI) equation and other creatinine-based equations in asian population: a systematic review. Int Urol Nephrol. 2016;48(9):1511–1517.
  • Delanaye P, Schaeffner E, Cozzolino M, et al. The new, race-free, chronic kidney disease epidemiology consortium (CKD-EPI) equation to estimate glomerular filtration rate: is it applicable in Europe? A position statement by the european federation of clinical chemistry and laboratory medicine (EFLM). Clin Chem Lab Med. 2023;61(1):44–47.
  • Vestergaard SV, Heide-Jorgensen U, Birn H, et al. Effect of the refitted Race-Free eGFR formula on the CKD prevalence and mortality in the danish population. Clin J Am Soc Nephrol. 2022;17(3):426–428.
  • Pottel H, Delanaye P. Development and validation of a modified full age spectrum Creatinine-Based equation to estimate glomerular filtration rate. Ann Intern Med. 2021;174(7):1038.
  • Delanaye P, Bjork J, Courbebaisse M, et al. Performance of creatinine-based equations to estimate glomerular filtration rate with a methodology adapted to the context of drug dosage adjustment. Br J Clin Pharmacol. 2022;88(5):2118–2127.
  • Shafi T, Zhu X, Lirette ST, et al. Quantifying Individual-Level inaccuracy in glomerular filtration rate estimation: a Cross-Sectional study. Ann Intern Med. 2022;175(8):1073–1082.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.